Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stock closed at 16.14 per share at the end of the most recent trading day (a 0.75% change compared to the prior day closing price) with a volume of 1.33M shares and market capitalization of 426.39M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 88 people. Arcturus Therapeutics Holdings Inc. CEO is Joseph E. Payne.

The one-year performance of Arcturus Therapeutics Holdings Inc. stock is -53.32%, while year-to-date (YTD) performance is -56.39%. ARCT stock has a five-year performance of 105.87%. Its 52-week range is between 11.7 and 65, which gives ARCT stock a 52-week price range ratio of 8.33%

Arcturus Therapeutics Holdings Inc. currently has a PE ratio of -1.80, a price-to-book (PB) ratio of 1.93, a price-to-sale (PS) ratio of 22.99, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -48.21%, a ROC of -58.18% and a ROE of -73.88%. The company’s profit margin is -84.18%, its EBITDA margin is -1 257.00%, and its revenue ttm is $15.48 Million , which makes it $0.59 revenue per share.

Of the last four earnings reports from Arcturus Therapeutics Holdings Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-1.84 for the next earnings report. Arcturus Therapeutics Holdings Inc.’s next earnings report date is 08th Aug 2022.

The consensus rating of Wall Street analysts for Arcturus Therapeutics Holdings Inc. is Hold (2.78), with a target price of $47.44, which is +193.93% compared to the current price. The earnings rating for Arcturus Therapeutics Holdings Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Arcturus Therapeutics Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Arcturus Therapeutics Holdings Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 31.04, ATR14 : 1.95, CCI20 : -18.11, Chaikin Money Flow : 0.09, MACD : -1.11, Money Flow Index : 64.46, ROC : -17.40, RSI : 48.17, STOCH (14,3) : 49.78, STOCH RSI : 1.00, UO : 56.65, Williams %R : -50.22), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Arcturus Therapeutics Holdings Inc. in the last 12-months were: Padmanabh Chivukula (Sold 58 100 shares of value $2 571 008 )